The Infectious Diseases Society of America (IDSA) on Friday revised its coronavirus treatment guidelines, recommending that the anti-malarial drug hydroxychloroquine not be used for COVID-19 patients. The IDSA initially only recommended against the use ...
from Google Alert - health https://ift.tt/3hl3SIs
via IFTTT
0 comments:
Post a Comment